|
Servicebio Inc
primary antibodies against p21 gb12153 Primary Antibodies Against P21 Gb12153, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/primary antibodies against p21 gb12153/product/Servicebio Inc Average 90 stars, based on 1 article reviews
primary antibodies against p21 gb12153 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Merck & Co
anti-p21 cip1/waf1 mouse monoclonal antibody (mab Anti P21 Cip1/Waf1 Mouse Monoclonal Antibody (Mab, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti-p21 cip1/waf1 mouse monoclonal antibody (mab/product/Merck & Co Average 90 stars, based on 1 article reviews
anti-p21 cip1/waf1 mouse monoclonal antibody (mab - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Merck & Co
anti-p21 mouse mab op64 ![]() Anti P21 Mouse Mab Op64, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti-p21 mouse mab op64/product/Merck & Co Average 90 stars, based on 1 article reviews
anti-p21 mouse mab op64 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Synaptic Systems
mouse monoclonal anti-p21-arc antibody ![]() Mouse Monoclonal Anti P21 Arc Antibody, supplied by Synaptic Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mouse monoclonal anti-p21-arc antibody/product/Synaptic Systems Average 90 stars, based on 1 article reviews
mouse monoclonal anti-p21-arc antibody - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Merck & Co
anti-p21 cip1/waf1 (ab-1) mouse mab (ea10) ![]() Anti P21 Cip1/Waf1 (Ab 1) Mouse Mab (Ea10), supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti-p21 cip1/waf1 (ab-1) mouse mab (ea10)/product/Merck & Co Average 90 stars, based on 1 article reviews
anti-p21 cip1/waf1 (ab-1) mouse mab (ea10) - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Biocare Medical
monoclonal mouse anti-human anti-p21 antibody wa-1 ![]() Monoclonal Mouse Anti Human Anti P21 Antibody Wa 1, supplied by Biocare Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/monoclonal mouse anti-human anti-p21 antibody wa-1/product/Biocare Medical Average 90 stars, based on 1 article reviews
monoclonal mouse anti-human anti-p21 antibody wa-1 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Cell Death & Disease
Article Title: The pharmalogical reactivation of p53 function improves breast tumor cell lysis by granzyme B and NK cells through induction of autophagy
doi: 10.1038/s41419-019-1950-1
Figure Lengend Snippet: a MDA-MB231 cells express high level of mutated p53 (p53 R280K ) lacking transcriptional activity as shown by the absence of p53-dependent transactivation of its target gene p21 even after γ-irradiation. b , c 24-48 h treatment with CP-31398 reactivates p53 transcriptional activity in MDA-MB231 cells as shown by induction of p21 expression at both mRNA ( b ) and protein ( c ) levels. d – f CP-31398-induced apoptosis and ROS production were evaluated after 48 h treatment using AnnexinV/PI ( d , e ) or DHE ( f ) staining. g , h CP-31398 treatment (48 h) increases MDA-MB231 cell susceptibility to NK-mediated lysis. 51 Cr release assay using NK92 ( d ) or NK cells isolated from a healthy donor ( e ) co-cultured with target cells at different E:T ratios are shown. i CP-31398 treatment increases MDA-MB231 cell susceptibility to NK-mediated lysis in a time dependent manner. A representative 51 Cr release assay (from two independent experiments) using NK cells isolated from a healthy donor is shown. j , k PFT-α (an inhibitor of p53 transcriptional activity) inhibits CP-31398-dependent induction of p21 expression in MDA-MB231 cells at both mRNA ( j ) and protein ( k ) levels. l , m PFT-α inhibits the increase of MDA-MB231 lysis by NK cells observed when CP-31398 is used alone. 51 Cr release assay using NK92 ( l ) or NK cells extracted from a healthy donor ( m ) co-cultured with target cells at the E:T ratio of 50:1 or 30:1, respectively, are shown. n – p The knockdown of mutated p53 expression using siRNA inhibits CP-31398-dependent induction of p21 expression in MDA-MB231 cells at both mRNA ( n ) and protein ( o ) levels and abrogate the CP-31398-dependent increase of MDA-MB231 lysis by NK cells ( p ). Data are representative of at least three independent experiments ( a , c , d , k , o ) or are the mean ± s.d. of three ( e – h , l , m , p ) or five ( b , j , n ) independent experiments. The p values (* P < 0.05; ** P < 0.01) were determined by unpaired two-tailed Student's t test ( b , e , g , h , j , l – n ) or one-way ANOVA ( p )
Article Snippet: From
Techniques: Activity Assay, Irradiation, Expressing, Staining, Lysis, Release Assay, Isolation, Cell Culture, Two Tailed Test
Journal: Cell Death & Disease
Article Title: The pharmalogical reactivation of p53 function improves breast tumor cell lysis by granzyme B and NK cells through induction of autophagy
doi: 10.1038/s41419-019-1950-1
Figure Lengend Snippet: a CP-31398 treatment (48 h) increases p21 and Mdm2 expression by MDA-MB231 cells, does not alter Bax level (used as control) and does not induce the degradation of Bcl-X L , XIAP, Bcl-2, Mcl-1, cIAP-1, IAP-2, or survivin. b The differences in the amount of LC3-II between samples in the presence and absence of chloroquine (CQ), representing the amount of LC3 that is degraded into autolysosomes, and allowing the measurement of the autophagic flux is represented. No additional LC3-II accumulation is observed when CP-31398 (48 h) is used in combination with CQ (2–24 h), showing that the autophagic flux induced by CP-31398 is blocked at the autophagosome-lysosome fusion step. c P62 expression level increases following 48 h treatment with CP-31398. d , e MDA-MB231 cells were transduced with LC3 fusion protein tagged with acid‑sensitive eGFP and acid‑insensitive RFP to monitor the specific loss of eGFP fluorescence upon acidification of the RFP + autophagosome following lysosomal fusion. Serum starvation induces autophagy with the loss of eGFP signal reflecting the fusion of autophagosomes with lysosomes. Fluorescence is seen from both eGFP and RFP channels after CP-31398 treatment, similarly to CQ that blocks autophagy through neutralization of lysosomal pH, demonstrating that CP-31398-induced autophagy flux is blocked at the autophagosomes/lysosomes fusion step. Dashed lines: plasma membrane. Scale bars: 10 μm ( c ). The percentage RFP + or RFP + /GFP + autophagosomes was evaluated in 100 cells after the indicated treatment ( d ). f Representative electron microscopy images of the autophagosomes containing undigested material presents in CP-31398 or chloroquine (CQ)-treated cells. Representative images of multivesicular bodies, mitochondria and endoplasmic reticulum are displayed as control. Data are representative of three independent experiments ( a – d , f ) or are the mean ± s.d. of three independent experiments ( e )
Article Snippet: From
Techniques: Expressing, Transduction, Fluorescence, Neutralization, Electron Microscopy
Journal: Current Health Sciences Journal
Article Title: P21 Immunoexpression in Actinic Keratosis and Cutaneous Carcinomas
doi: 10.12865/CHSJ.43.03.07
Figure Lengend Snippet: p21 immunostaining: A. Actinic keratosis (KIN I), x100; B. well differentiated squamous carcinoma, x100; C. moderate differentiated squamous carcinoma, x100; D. poorly differentiated squamous carcinoma, x100
Article Snippet: In this study we use a
Techniques: Immunostaining
Journal: Current Health Sciences Journal
Article Title: P21 Immunoexpression in Actinic Keratosis and Cutaneous Carcinomas
doi: 10.12865/CHSJ.43.03.07
Figure Lengend Snippet: Distribution of the actinic keratosis cases depending of p21 FSS
Article Snippet: In this study we use a
Techniques:
Journal: Current Health Sciences Journal
Article Title: P21 Immunoexpression in Actinic Keratosis and Cutaneous Carcinomas
doi: 10.12865/CHSJ.43.03.07
Figure Lengend Snippet: Distribution of the squamous carcinomas cases depending on p21 FSS
Article Snippet: In this study we use a
Techniques:
Journal: Current Health Sciences Journal
Article Title: P21 Immunoexpression in Actinic Keratosis and Cutaneous Carcinomas
doi: 10.12865/CHSJ.43.03.07
Figure Lengend Snippet: Distribution of the positive p21 carcinomas depending on differentiation degree (A) and tumor stage (B)
Article Snippet: In this study we use a
Techniques: